Literature DB >> 55535

Hyperprolactinaemia and luteal insufficiency.

M Seppälä, T Ranta, E Hirvonen.   

Abstract

Prolactin interferes with the function of the corpus luteum, as was demonstrated by repeatedly finding a short luteal phase in the ovulatory cycles of two hyperprolactinaemic women after prolactin supression by bromocriptine had been discontinued. In hyperprolactinaemic ovulatory cycles excretion of pregnanediol in urine was less and plasma-progesterone concentrations were lower than in normo-prolactinaemic cycles. When the amenorrhoea-galactorrhoea syndrome recurred the symptoms appeared in the following order: (1) serum-prolactin increased and the luteal phase became shorter; (2) galactorrhoea appeared; (3) ovulation was missed; (4) menstruation was missed. All these abnormalities may be treated by prolactin suppression, but the effect of treatment does not persist for long after bromocriptine administration ceases.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 55535     DOI: 10.1016/s0140-6736(76)91343-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  16 in total

Review 1.  Biochemical diagnosis in prolactinomas: some caveats.

Authors:  Stephan Petersenn
Journal:  Pituitary       Date:  2020-02       Impact factor: 4.107

2.  Higher TSH Levels Within the Normal Range Are Associated With Unexplained Infertility.

Authors:  Tahereh Orouji Jokar; Lindsay T Fourman; Hang Lee; Katherine Mentzinger; Pouneh K Fazeli
Journal:  J Clin Endocrinol Metab       Date:  2018-02-01       Impact factor: 5.958

3.  Serum prolactin response to embryo transfer during human in vitro fertilization and embryo transfer.

Authors:  S P Boyers; G Lavy; J B Russell; M L Polan; A H DeCherney
Journal:  J In Vitro Fert Embryo Transf       Date:  1987-10

Review 4.  Do nothing but observe microprolactinomas: when and how to replace sex hormones?

Authors:  Vivien Bonert
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

5.  PRL, TSH, and thyroid hormones in benign breast diseases.

Authors:  F Peters; C R Pickardt; G Zimmermann; M Breckwoldt
Journal:  Klin Wochenschr       Date:  1981-04-15

6.  Effects of synthetic gestagens on serum prolactin and growth hormone secretion in amenorrheic patients.

Authors:  H G Bohnet; N G Naber; E del Pozo; H P Schneider
Journal:  Arch Gynecol       Date:  1978-11-30

7.  Serum prolactin and progesterone concentrations in ovulatory infertility.

Authors:  T Ranta; P Lehtovirta; U H Stenman; M Seppälä
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

Review 8.  Use of bromocriptine in hyperprolactinaemic anovulation and related disorders.

Authors:  S Franks
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

Review 9.  Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent miscarriage history.

Authors:  Hengxi Chen; Jing Fu; Wei Huang
Journal:  Cochrane Database Syst Rev       Date:  2016-07-25

10.  Prolactin oversuppression.

Authors:  H G Bohnet; D Mühlenstedt; J P Hanker; H P Schneider
Journal:  Arch Gynakol       Date:  1977-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.